Functional Diffusion Mapping (fDM) for Quantitative DW-MRI to Predict Breast Cancer Response to Neoadjuvant Chemotherapy

DW-MRI has been used to predict treatment response in breast cancer. Studies have shown the ability of the functional diffusion mapping (fDM) method applied on DW-MRI as an early biomarker for survival for patients with brain tumor. However, there is only one study reporting the fDM analysis on breast cancer data. In this study, we attempted to determine 1) if fDM performed on patients with breast cancer can be used to separate responders from non-responders, and 2) does the fDM approach outperform simple region of interest based analysis. The results indicate that the fDM approach on the DW-MRI breast data retains the information of tumor heterogeneity, therefore allowing for an improved ability to predict treatment response when compared to a standard region of interest based analysis.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.